Mark Mallon Insider Trading
Get free email notifications about insider trading for Mark Mallon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Mallon. Mark Mallon is an Chief Executive Officer in NEOGENOMICS INC ($NEO) and an Chief Executive Officer in IRONWOOD PHARMACEUTICALS INC ($IRWD) and an Executive Senior Advisor in IRONWOOD PHARMACEUTICALS INC ($IRWD).
Address: C/O IRONWOOD PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE 02142 MA
Companies in which Mark Mallon is an Insider
IRONWOOD PHARMACEUTICALS INC
Trading Symbol: IRWDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Mallon: Chief Executive Officer, Executive Senior Advisor
Holdings: 493,187 shares
Current Value: $7,772,627
Latest Transaction: Mar 02 2021
$IRWD Market Capitalization: $2.32B
$IRWD Previous Close: $15.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEOGENOMICS INC
Trading Symbol: NEOIndustry: SERVICES-TESTING LABORATORIES [8734]
Position of Mark Mallon: Chief Executive Officer
Holdings: 55,736 shares
Current Value: $448,117
Latest Transaction: Apr 21 2021
$NEO Market Capitalization: $625.74M
$NEO Previous Close: $8.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Mallon
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2021 | NEO | NEOGENOMICS INC | Mallon Mark | Chief Executive Off ... | Option Exercise | A | 49.34 | 151,016 | 7,451,129 | 151,016 | |
Apr 21 2021 | NEO | NEOGENOMICS INC | Mallon Mark | Chief Executive Off ... | Grant | A | 0.00 | 55,736 | 0 | 55,736 | 0 to 55.7 K |
Mar 02 2021 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 9.11 | 22,582 | 205,722 | 470,605 | 493.2 K to 470.6 K (-4.58 %) |
Mar 02 2021 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 9.11 | 8,093 | 73,727 | 493,187 | 501.3 K to 493.2 K (-1.61 %) |
May 13 2020 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 10.35 | 23,206 | 240,182 | 501,280 | 524.5 K to 501.3 K (-4.42 %) |
Feb 25 2020 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 11.25 | 1 | 11 | 303,425 | 303.4 K to 303.4 K (0.00 %) |
Feb 25 2020 | IRWD | IRONWOOD PHARMACEU ... | Mallon Mark | Chief Executive Off ... | Sell | S | 11.63 | 7,983 | 92,842 | 303,426 | 311.4 K to 303.4 K (-2.56 %) |